Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2081965 | Drug Discovery Today: Disease Mechanisms | 2006 | 5 Pages |
Abstract
Angiotensin-converting enzyme 2 (ACE2) counterbalances with ACE and functions as a negative regulator of the renin–angiotensin system (RAS). The importance of RAS in acute respiratory distress syndrome (ARDS) has recently re-emerged owing to the identification of ACE2 as a receptor for the SARS-coronavirus. Recent studies have demonstrated that ACE2 protects mice from acute lung injury as well as SARS-mediated lung injury. We review the role of the RAS, in particular ACE2, in the pathogenesis of ARDS.
Section editors:Terry Delovitch – The John P. Robarts Research Institute, London, Ont., CanadaDavid Scott – University of Maryland School of Medicine, Baltimore, MD, USA
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Yumiko Imai, Keiji Kuba, Josef M. Penninger,